Use of CD14 transfected cells to study LPS-antagonist action.
Evans Department of Clinical Research, Boston University School of Medicine Hospital, MA 02118, USA.
R L
RL
Delude
R
R
Savedra
S
S
Yamamoto
D T
DT
Golenbock
D000818:Animals; D016718:Arachidonic Acid / Q000096:biosynthesis; D001693:Biological Transport, Active; D016466:CHO Cells; D002460:Cell Line; D006224:Cricetinae; D006017:Glycolipids / Q000494:pharmacology; D006801:Humans; D008050:Lipid A / Q000031:analogs & derivatives / Q000494:pharmacology; D018950:Lipopolysaccharide Receptors / Q000235:genetics* / Q000378:metabolism; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000633:toxicity; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism; D015398:Signal Transduction; D014162:Transfection
D006017:Glycolipids; D008050:Lipid A; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D016328:NF-kappa B; C040142:lipid A precursors, bacterial; D016718:Arachidonic Acid